Analyst Recommendations

35.27 0.29(0.83%)07/03/2024
Apellis Pharmaceuticals Inc (APLS)


2024: Total Recommendations Consensus
To Grade# of Recommendations
Buy15
Neutral6
Outperform4
Equal-Weight1
Overweight1
Strong Buy1

5 records were shown. To view all data, Upgrade to PRO plan with only $1


Upgrades & Downgrades